Overview
Submission Instructions
Recent Publications
Frequently Asked Questions
Research Topics
Looking to publish in The Oncologist? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer login
TO
The Oncologist is a journal focused on oncology and hematology and publishes timely reviews, original studies, and commentaries on important developments in the field.
Looking to publish in The Oncologist? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.
Existing customer login
Subject
Oncology
Impact Factor
4.2
Quartile
Q2
Open Access Type
Hybrid
ISSN
1083-7159
eISSN
1549-490X
Invitation Only
No
Cost Range
Article Processing Charges usually apply for fully open access journals and for gold open access in hybrid journals; waivers or discounts are available for corresponding authors in qualifying low- and middle-income countries publishing in fully open access journals.
Submission Instructions
The Oncologist accepts the following article types. Click on an article type to view submission instructions.
Original Article
Cover Letter
A cover letter should accompany the submission. The cover letter must briefly describe the work’s significance and identify the corresponding author with their complete mailing address.
Abstract
Original Articles must include an abstract. The abstract must not exceed 250 words. The abstract must be structured. The abstract must use the headings Background, Materials and Methods or Patients and Methods, Results, and Conclusion.
Manuscript
The manuscript text must not exceed 4,000 words. The text should be organized in the following order when appropriate: Introduction, Materials and Methods, Results, Discussion, Conclusion and/or Summary, Acknowledgments, Disclosure of Potential Conflicts of Interest, Author Contributions, Data Availability Statement, References, Figure legends, Tables, and Figures. Original Articles must include an Implications for Practice statement of less than 100 words that clearly explains the manuscript’s potential clinical impact in language comprehensible to a lay reader whenever possible.
References
References must not exceed 100 entries. References must follow American Medical Association parent style. References must be numbered in the order in which they are cited in the text.
Figures & Tables
Original Articles may include a maximum of 7 display items. Tables must not be embedded within the manuscript and must be submitted as separate .doc files, and each figure must be submitted as an individual image file with legends included in the manuscript. Tables and figures must be numbered in the order cited in the text, tables must be titled, and figures must have legends.
Review Article
Cover Letter
A cover letter should accompany the submission. The cover letter must briefly describe the work’s significance and identify the corresponding author with the corresponding author’s complete mailing address.
Abstract
An abstract is required for Review Articles. The abstract must not exceed 250 words. The abstract may be structured or unstructured at the authors’ preference.
Manuscript
The manuscript must not exceed 4,000 words. The text should be divided in order into Introduction, Materials and Methods, Results, Discussion, Conclusion and/or Summary, Acknowledgments, Disclosure of Potential Conflicts of Interest, Author Contributions, Data Availability Statement, References, Figure legends, Tables, and Figures when appropriate, and Review Articles must include a Materials and Methods section detailing how the literature review was planned, selection criteria, use of levels of evidence, and whether unpublished material was included. Review Articles must include an Implications for Practice statement of less than 100 words that clearly defines the manuscript’s potential clinical impact in lay-comprehensible language whenever possible.
References
References must not exceed 150. References must follow American Medical Association parent style. References must be numbered in the order they are cited in the text.
Figures & Tables
Review Articles must not exceed 7 figures and tables in total, and additional figures or tables should be provided as supplementary material. Tables must not be embedded within the manuscript, tables must be submitted as individual .doc files, figure titles and legends must appear in the manuscript file, and each figure must be submitted as an individual image file. Tables and figures must be numbered in the order they are cited in the text, tables must be titled, and figures must have a legend.
Clinical Trial Results
Cover Letter
A cover letter should accompany the submission. Cover letter must briefly describe the work’s significance and identify the corresponding author with the corresponding author’s complete mailing address.
Abstract
Abstract is required. Abstract must be 250 words or less. Abstract must be structured. Abstract must include the headings Background, Methods, Results, and Conclusion, and the conclusion must include the ClinicalTrials.gov identifier.
Manuscript
Main text must not exceed 1,500 words, and the Discussion section should be less than 1000 words. Manuscript must use the CTR submission template and include Lessons Learned, trial information, drug information, study arm details, patient cohort description, assessment methods, response assessments, toxicity tables, and a Discussion stating whether the study was completed or terminated and summarizing the investigators’ assessment. Manuscript must include 1 to 3 bullet-point Lessons Learned and four to six keywords or phrases on the first page.
References
References must follow AMA style. References must be numbered in the order in which they are cited in the text.
Figures & Tables
There is no firm figure or table count limit. Additional figures and tables should be placed at the end of the file in the Figures and Tables section, while journal-level table instructions also state that tables must not be embedded within the manuscript and must be submitted as individual .doc files. Tables must be provided as text rather than images, additional tables must match the template formatting, serious adverse events tables must report one patient per row, general toxicity profiles must use CTCAE, and Dose Limiting Toxicities must be presented in table format.
Brief Communications
Cover Letter
A cover letter should accompany the submission. Cover letter must briefly describe the work’s significance and identify the corresponding author with the corresponding author’s complete mailing address.
Abstract
Text abstract is required.
Manuscript
Manuscript is limited to 1,000 words. The first page must include four to six keywords or phrases.
References
References are limited to 10. References must follow American Medical Association parent style. References must be numbered in the order in which they are cited in the text.
Figures & Tables
Brief Communications may include a maximum of 2 display items. Tables must not be embedded within the manuscript, tables must be submitted as individual files, figure legends must be included in the manuscript file, and each figure must be submitted as an individual image file. Tables, figures, and legends must be numbered in the order in which they are cited in the text.
Precision Medicine Clinic: Molecular Tumor Board
Cover Letter
A cover letter should accompany the submission and briefly describe the work’s significance while identifying the corresponding author and giving the corresponding author’s complete mailing address. The cover letter must briefly describe the work’s significance, identify the corresponding author, and include the corresponding author’s complete mailing address.
Abstract
An abstract is required.
Manuscript
Manuscript length is limited to 2,000 words. Manuscript must include an Abstract, Key Points, a Patient Story, a Molecular Tumor Board section, a Patient update, References, Figures, Tables, and a Glossary of genomic terms and nomenclature. The Molecular Tumor Board section must include genotyping results and interpretation of the molecular results, the functional and clinical significance of the specific mutation in the particular cancer, and potential strategies to target the pathway with implications for clinical practice.
References
References are limited to a maximum of 25. References must follow American Medical Association parent style. References must be numbered in the order in which they are cited in the text.
Figures & Tables
Submissions may include up to 4 display items. Tables must not be embedded within the manuscript and must be submitted as individual files, while figure titles and legends must be included in the manuscript file and each figure submitted as an individual image file. Tables are required, including considerations for clinical management while reviewing a molecular alteration report in clinic, and figures must have legends.
Letters To The Editor
Cover Letter
Cover letter should accompany the submission. Cover letter must briefly describe the work's significance and identify the corresponding author with their complete mailing address.
Abstract
Abstract requirements are not specified.
Manuscript
Letters to the Editor must not exceed 500 words. Letters to the Editor must pertain to papers published in the past year. The first page must include a title of no more than 150 characters, a running head of no more than 50 characters, author names, Author Contributions using CRediT, main-text word count, any disclaimers, a brief acknowledgment of support, and four to six MeSH-based keywords or phrases.
References
Letters to the Editor may include no more than 10 references. References must follow AMA parent style. References must be numbered in the order they are cited in the text.
Figures & Tables
Letters to the Editor may include a maximum of 1 display item. Tables must not be embedded within the manuscript, must be submitted as individual .doc files, and figure legends must appear in the manuscript while each figure is uploaded as an individual file. Tables and figures must be numbered in the order cited, tables must be titled, and all images must include alt text placed under the relevant figure legend in the manuscript.
Recent Publications
Clinical and Molecular Response to Vorasidenib in Post-Transplant Patient with IDH2-mutant Intrahepatic Cholangiocarcinoma
Vivian V Altiery De Jesus, Timothy McMahon, Sara E Young, Daniel J Zabransky, Mark Yarchoan, Marina Baretti
10.1093/oncolo/oyag228
View Publication
Evaluation of the efficacy of topical cosmetic products in patients with hand-and-foot syndrome undergoing oncological treatments
Antonia Martuscelli, Giulio Tosti, Patrick Maisonneuve, Carolina Redaelli, Mirella Indino, Martina Cereda, Giuseppe Curigliano, Ida Minchella
10.1093/oncolo/oyag233
View Publication
Women’s Health Across the Reproductive Lifespan in Women with Germline TP53 Pathogenic Variants: A Clinical Perspective
Naama Halpern, Rinat Bernstein-Molho, Yehudit Peerless, Iris Kventsel, Zehavit Frenkel, Yossi Mizrachi, Hagit Shani, Myriam Safrai
10.1093/oncolo/oyag212
View Publication
Association between endocrine therapy and survival outcomes in estrogen receptor–low breast cancer: a systematic review and meta-analysis
Fan Xia, XiaoBo Hu, Lei Zhang, XiaoDong Peng, Mei Xie
10.1093/oncolo/oyag230
View Publication
A phase II clinical trial of albumin-bound paclitaxel, cisplatin, gemcitabine (NABPLAGEM) and paricalcitol as neoadjuvant therapy in pancreatic cancer
Alexa F Viniotis, Gayle S Jameson, Betsy C Wertheim, Denise J Roe, Keehoon Lee, Frank Y Tsai, Michael S Gordon, Sunil Sharma, Carol M Guarnieri, Courtney E Snyder, Amar J Thosani, Albert Amini, Steven E Sckolnik, Jacqueline M Garrick, Ronald L Korn, Syed Rahmanuddin, Ronald M Evans, Michael Downes, Morgan Truitt, Daniel D Von Hoff, Erkut H Borazanci
10.1093/oncolo/oyag232
View Publication
Frequently asked questions
How long does it take to publish?
Accepted Manuscript is published within one week after acceptance and signing the publishing agreement.
Reformat to The Oncologist using Livewrite PremiumIs a cover letter required?
Submissions should be accompanied by a cover letter briefly describing the work’s significance and identifying the corresponding author, including complete mailing address, telephone number, and email address. The cover letter must also disclose related or similar previously published or under-consideration materials.
Reformat to The Oncologist using Livewrite PremiumWhat are the publication costs?
Article Processing Charges usually apply for fully open access journals and for gold open access in hybrid journals; waivers or discounts are available for eligible corresponding authors in qualifying countries publishing in fully open access journals.
Reformat to The Oncologist using Livewrite PremiumResearch Topics
Lung Cancer Treatments and Mutations
Cancer Immunotherapy and Biomarkers
Colorectal Cancer Treatments and Studies
Cancer Treatment and Pharmacology
Breast Cancer Treatment Studies
HER2/EGFR in Cancer Research
Cancer Genomics and Diagnostics
Lung Cancer Research Studies
Cancer survivorship and care
Economic and Financial Impacts of Cancer
Renal cell carcinoma treatment
Advanced Breast Cancer Therapies
Pancreatic and Hepatic Oncology Research
Global Cancer Incidence and Screening
Lymphoma Diagnosis and Treatment
Hepatocellular Carcinoma Treatment and Prognosis
Palliative Care and End-of-Life Issues
Lung Cancer Diagnosis and Treatment
Gastric Cancer Management and Outcomes
Neuroendocrine Tumor Research Advances
Prostate Cancer Treatment and Research
Health Systems, Economic Evaluations, Quality of Life
Ovarian cancer diagnosis and treatment
BRCA gene mutations in cancer
Head and Neck Cancer Studies